NCT06154200View on ClinicalTrials.gov

Eyelid Androgen Treatment in Dry Eye

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 2, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

May 30, 2024

Conditions
Aqueous Tear DeficiencyMeibomian Gland Dysfunction of Bilateral Eyes (Disorder)
Interventions
DRUG

Testosterone gel 4.5%

Testosterone gel applied to eyelids twice per day

DRUG

Vehicle gel

Vehicle gel applied to eyelids twice per day

Trial Locations (1)

92831

Southern California College of Optometry at Marshall B. Ketchum University, Fullerton

All Listed Sponsors
lead

Southern California College of Optometry at Marshall B. Ketchum University

OTHER